-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $103

Benzinga·12/08/2025 15:38:41
Listen to the news
Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $99 to $103.